Atazanavir sulfate
Cat. No.：YN360613
CAS No. ：229975-97-7
| 产品名称: | Atazanavir sulfate |
| CAS No.: | 229975-97-7 |
| Chemical Name: | 3,12-Bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-dimethyl Ester, (3S,8S, 9S, 12S)-2,5,6,13-Pentaazatetradecanedioic Acid; BMS-232632; CGP-73547; Reyataz; |
| Synonyms: | 硫酸阿扎那韦; BMS-232632 sulfate |
| 分子量: | 802.93 |
| 分子式: | C₃₈H₅₄N₆O₁₁S |
| SMILES: | O=C(OC)N[C@@H](C(C)(C)C)C(NN(CC1=CC=C(C2=NC=CC=C2)C=C1)C[C@H](O)[C@H](CC3=CC=CC=C3)NC([C@H](C(C)(C)C)NC(OC)=O)=O)=O.O=S(O)(O)=O |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Atazanavir sulfate (BMS-232632 sulfate) 是一种高选择性的HIV-1蛋白酶抑制剂，用于艾滋病毒感染的研究。Atazanavir sulfate (BMS-232632 sulfate) 是CYP3A4的底物和抑制剂，也是P-糖蛋白的抑制剂和诱导剂。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Palella, F.J. Jr., et al.: N. Engl. J. Med., 338(13), 853 (1998), Nolan, D., et al.: Drugs, 63(23), 2555 (2003), Musial, B.L., et al.: Am. J. Health Syst. Pharm., 61, 1365 (2004), Wood, R., et al.: J. Acquir. Immune Defic. Syndr., 36, 684 (2004),
